Find research datasets worth reusing

Study of Exposure to Stress, Postpartum Mood, Adverse Life Events, and Hormonal Function Among Latinas (SEPAH Latina)

ClinicalTrials.gov study NCT01912833. IPD Sharing: Not stated. Countries: 1. Publications: 0.

The COVID-19 Disease and CARdiac Events Study

ClinicalTrials.gov study NCT04438993. IPD Sharing: NO. Countries: 1. Publications: 0.

Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 6 and 17 Years With Moderate to Severe Plaque Psoriasis Treated With Subcutaneous (SC) Injection of Risankizumab

ClinicalTrials.gov study NCT04862286. IPD Sharing: YES. Countries: 7. Publications: 0.

A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

ClinicalTrials.gov study NCT06291220. IPD Sharing: NO. Countries: 5. Publications: 0.

An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World Practice

ClinicalTrials.gov study NCT05494606. IPD Sharing: UNDECIDED. Countries: 17. Publications: 0.

A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD Event

ClinicalTrials.gov study NCT07000123. IPD Sharing: YES. Countries: 22. Publications: 0.

A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ank

ClinicalTrials.gov study NCT04541810. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.

Study to Assess Adverse Events and How Oral ABBV-990 Moves Through the Body of Adult Healthy Participants

ClinicalTrials.gov study NCT05475821. IPD Sharing: NO. Countries: 1. Publications: 0.

A Study of Detection of Paroxysmal Events Utilizing Computer Vision and Machine Learning (USF)

ClinicalTrials.gov study NCT06705439. IPD Sharing: NO. Countries: 1. Publications: 0.

A Study to Assess Adverse Events and Effectiveness of OnabotulinumtoxinA Intramuscular Injections for the Change of Moderate to Severe Forehead Lines in Adult Participants

ClinicalTrials.gov study NCT06794866. IPD Sharing: YES. Countries: 1. Publications: 0.

A Study to Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Participants Requiring High Dose Corticosteroids for Active Non-Infectious Intermediate, Posterior, or Pan-Uvei

ClinicalTrials.gov study NCT05414201. IPD Sharing: YES. Countries: 1. Publications: 0.

Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Unt

ClinicalTrials.gov study NCT06191744. IPD Sharing: YES. Countries: 32. Publications: 0.

A Study to Evaluate the Efficacy and Safety of GDC-8264 in Preventing Cardiac Surgery-Associated Acute Kidney Injury (AKI) and Major Adverse Kidney Events (MAKE)

ClinicalTrials.gov study NCT06602453. IPD Sharing: YES. Countries: 12. Publications: 0.

Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellula

ClinicalTrials.gov study NCT05822752. IPD Sharing: YES. Countries: 7. Publications: 0.

EXACERBATIONS AND REAL-WORLD OUTOMES INCLUDING CARDIOPULMONARY EVENTS AMONG PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (MITOS: EROS+CP US Study)

ClinicalTrials.gov study NCT06742736. IPD Sharing: Not stated. Countries: 1. Publications: 0.

Study to Assess Effectiveness and Adverse Events of JUVEDERM VOLBELLA With Lidocaine Injection in Correcting Infraorbital Hollowing in Chinese Adult Participants

ClinicalTrials.gov study NCT05088980. IPD Sharing: YES. Countries: 1. Publications: 0.

A Study to Evaluate Adverse Events and How the Drug Moves Through the Body From Subcutaneous (SC) and Intravenous (IV) Doses of ABBV-382 in Healthy Adult Chinese Volunteers

ClinicalTrials.gov study NCT06632938. IPD Sharing: NO. Countries: 1. Publications: 0.

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post

ClinicalTrials.gov study NCT07023289. IPD Sharing: YES. Countries: 7. Publications: 0.

A Study to Assess Adverse Events and Change in Disease Activity of JUVÉDERM® VOLITE™ XC Injectable Gel for Change in Neck Appearance in Adult Participants

ClinicalTrials.gov study NCT05316233. IPD Sharing: YES. Countries: 1. Publications: 0.

Finnish Genetic Study for Arrhythmic Events

ClinicalTrials.gov study NCT02075866. IPD Sharing: Not stated. Countries: 1. Publications: 0.